Increasing Placebo Response Rates and the Threat to Clinical Trials: How Will We Identify Effective Treatments for Rheumatic Disorders?

Documenti analoghi

• Global Recruiting Patterns and Placebo Response Rates in Clinical Trials of Psoriatic Arthritis and Plaque Psoriasis
  di: Andreas Kerschbaumer, et al.
  Pubblicazione: (2025)
• A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis
  di: Carol A. Langford, et al.
  Pubblicazione: (2025)
• Cytokine Profiling of Systemic Sclerosis–Related Pulmonary Hypertension
  di: Justin K. Lui, et al.
  Pubblicazione: (2026)
• Do We Need More Exercise and Osteoarthritis Randomized Clinical Trials?
  di: Stephen P. Messier
  Pubblicazione: (2024)
• Correction to “A Randomized, Double‐Blind, Placebo‐Controlled Trial of Abatacept for the Treatment of Relapsing, Nonsevere Granulomatosis With Polyangiitis”
  Pubblicazione: (2026)